JPRN-UMIN000004075已完成未知
A randomized phase 2 study of maintenance pemetrexed versus docetaxel following pemetrexed plus carboplatin in advanced non-small cell lung cancer - Maintenance pemetrexed versus docetaxel following pemetrexed plus carboplatin
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criterias are as follows 1: Squamous cell carcinoma 2: Active interstitial pneumonia identified by chest X-ray 3: Uncontrolled massive pleural effusion or cardiac effusion 4: Superior vena cava syndrome 5: Uncontrolled brain metastases 6: Uncontrolled diabetes mellitus, hypertension, hepatic disorder, angina pectoris or previous myocardial infarction within the last 12 months 7: Severe infection 8: Pregnancy or lactation 9: Active concomitant malignancy 10: History of severe allergic reactions to drugs 11: Severe and unstable medical comorbidities 12: Judgment to attending physician
研究者
相似试验
招募中
不适用
Randomized phase II study of maintenance pemetrexed, bevacizumab, and pemetrexed+bevacizumab after induction chemotherapy with carboplatin+pemetrexed in advanced nonsquamous NSCLC.nonsquamous NSCLCJPRN-UMIN000006620Kyoto Thoracic Oncology Research Group99
已完成
不适用
Phase II study of pemetrexed maintenance with or without bevacizumab after a first line treatment chemotherapy with bevacizumab-carboplatin-pemetrexed in patients with advanced, metastatic or recurrent non-squamous non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000010002Internal Medicine 2, Hamamatsu University School of Medicine.110
进行中（未招募）
不适用
Maintenance in elderly patient advanced Lung CancerEUCTR2012-005520-15-FRIFCT
进行中（未招募）
不适用
A randomized phase II trial of pemetrexed with or without PF-3512676 for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of one prior chemotherapy regimen for advanced diseaseTreatment of patients with locally advanced or metastatic non-small lung cancer (NSLC) after failure of one prior chemotherapy regimen for advanced diseaseMedDRA version: MedLevel: VTcClassification code 10061873EUCTR2006-001588-52-DEPfizer Pharma GmbH130
招募中
2 期
A randomized phase II study of pemetrexed versus pemetrexed plus carboplatin in chemotherapy-naive elderly patients with IIIB/IV non-squamous non-small cell lung cancer.JPRN-UMIN000006129Division of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University60